CVE-2026-66875 Mira Hormone Monitor, Mira Android App Missing authentication for critical function
Remote attackers can rebind the device, steal hormone data, and cause denial of service due to missing authentication in the firmware and app.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2026-66875?
CVE-2026-66875 is a high-severity missing authorization vulnerability in Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App, published on 11 Aug 2026. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.
Weakness: CWE-306
Which versions are affected by CVE-2026-66875?
How do I fix CVE-2026-66875?
No fix has been published for CVE-2026-66875 yet. Limit exposure of the affected software until one is available.
Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.
Is CVE-2026-66875 being exploited?
There is no known exploitation of CVE-2026-66875 in the wild and no public exploit code.
Sources
Also known as GHSA-hqrj-p65x-4mf9.